TLX Financials: Telix Pharmaceuticals Limited AI Analysis



Financials

TLX Financial

Telix Pharmaceuticals Limited

$10.09

1.5%

$0.15

At close: Jun 18, 16:00:00 GMT-4

$9.89

-1.98%

$-0.19

Post-market: Jun 18, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$9.94

Open

$10.01

Day's Range

$9.89 - $10.16

52 week range

$6.28 - $17.25

Volume

77.0K

Avg.Volume

194.7K

Dividend yield

EPS (TTM)

-0.02

Market Cap

$3.3B

Features

Markets

News

Breakdown	TTM	01/31/2026	10/31/2025	07/31/2025	04/30/2025	01/31/2025
Revenue	1,671	410	421	396	442	404
Revenue Growth (YoY)	-2%	1%	-1%	-2%	-6%	-12%
Cost of Revenue	432	107	104	109	110	104
Gross Profit	1,238	302	317	287	331	300
Selling, General & Admin	914	219	225	240	229	229
Research & Development	--	--	--	--	--	--
Operating Expenses	966	232	238	253	242	243
Other Non Operating Income (Expenses)	-2	-1	-1	0	1	1
Pretax Income	172	44	58	17	52	18
Income Tax Expense	18	14	13	6	-15	41
Net Income	154	29	44	11	68	-22
Net Income Growth	276%	-231.99%	10%	-1,200%	172%	-81%
Shares Outstanding (Diluted)	52.65	52.65	53.51	53.96	54.87	53.95
Shares Change (YoY)	-2%	-2%	-2%	-1%	1%	-1%
EPS (Diluted)	2.93	0.56	0.83	0.21	1.24	-0.42
EPS Growth	291%	-231.99%	14%	-921%	168%	-80%
Free Cash Flow	188	166	-4	-97	123	132
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	74.08%	73.65%	75.29%	72.47%	74.88%	74.25%
Operating Margin	16.21%	16.82%	18.76%	8.58%	19.9%	14.1%
Profit Margin	9.21%	7.07%	10.45%	2.77%	15.38%	-5.44%
Free Cash Flow Margin	11.25%	40.48%	-0.95%	-24.49%	27.82%	32.67%
EBITDA	400	100	111	66	120	89
EBITDA Margin	23.93%	24.39%	26.36%	16.66%	27.14%	22.02%
D&A For EBITDA	129	31	32	32	32	32
EBIT	271	69	79	34	88	57
EBIT Margin	16.21%	16.82%	18.76%	8.58%	19.9%	14.1%
Effective Tax Rate	10.46%	31.81%	22.41%	35.29%	-28.84%	227.77%

Breakdown

TTM

01/31/2026

10/31/2025

07/31/2025

04/30/2025

01/31/2025

Revenue

1,671

410

421

396

442

404

Revenue Growth (YoY)

-2%

-1%

-2%

-6%

-12%

Cost of Revenue

432

107

104

109

110

104

Gross Profit

1,238

302

317

287

331

300

Selling, General & Admin

914

219

225

240

229

Research & Development

Operating Expenses

966

232

238

253

242

243

Other Non Operating Income (Expenses)

-2

-1

Pretax Income

172

Income Tax Expense

-15

Net Income

154

-22

Net Income Growth

276%

-231.99%

10%

-1,200%

172%

-81%

Shares Outstanding (Diluted)

52.65

53.51

53.96

54.87

53.95

Shares Change (YoY)

-2%

-1%

EPS (Diluted)

2.93

0.56

0.83

0.21

1.24

-0.42

EPS Growth

291%

-231.99%

14%

-921%

168%

-80%

Free Cash Flow

188

166

-4

-97

123

132

Free Cash Flow Per Share

Gross Margin

74.08%

73.65%

75.29%

72.47%

74.88%

74.25%

Operating Margin

16.21%

16.82%

18.76%

8.58%

19.9%

14.1%

Profit Margin

9.21%

7.07%

10.45%

2.77%

15.38%

-5.44%

Free Cash Flow Margin

11.25%

40.48%

-0.95%

-24.49%

27.82%

32.67%

EBITDA

400

100

111

120

EBITDA Margin

23.93%

24.39%

26.36%

16.66%

27.14%

22.02%

D&A For EBITDA

129

EBIT

271

EBIT Margin

16.21%

16.82%

18.76%

8.58%

19.9%

14.1%

Effective Tax Rate

10.46%

31.81%

22.41%

35.29%

-28.84%

227.77%

Follow-Up Questions

What are Telix Pharmaceuticals Limited's key financial statements?



According to the latest financial statement (Form-10K), John Wiley & Sons Inc has a total asset of $0, Net loss of $0

What are the key financial ratios for TLX?



John Wiley & Sons Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Telix Pharmaceuticals Limited's revenue broken down by segment or geography?



Currently John Wiley & Sons Inc data is not available.

Is Telix Pharmaceuticals Limited profitable?



no, according to the latest financial statements, John Wiley & Sons Inc has a net loss of $0

Does Telix Pharmaceuticals Limited have any liabilities?



no, John Wiley & Sons Inc has liability of 0

How many outstanding shares for Telix Pharmaceuticals Limited?



John Wiley & Sons Inc has a total outstanding shares of 0

Telix Pharmaceuticals Limited (TLX) Financial

TLX Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

Telix Pharmaceuticals Limited (TLX) Financial

TLX Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

TLX Income

Follow-Up Questions

What are Telix Pharmaceuticals Limited's key financial statements?

What are the key financial ratios for TLX?

How is Telix Pharmaceuticals Limited's revenue broken down by segment or geography?

Is Telix Pharmaceuticals Limited profitable?

Does Telix Pharmaceuticals Limited have any liabilities?

How many outstanding shares for Telix Pharmaceuticals Limited?